News
Drug granted priority review for relapsed/refractory AML
The US Food and Drug Administration (FDA) has granted priority review for the new drug application (NDA) for enasidenib (AG-221), an inhibitor of...
News
Hospital floors pose infection risk, team says
Hospital room floors may be an overlooked source of infection, according to a study published in the American Journal of Infection Control....
News
Antithrombotic drugs may raise risk of subdural hematoma
Use of antithrombotic drugs is associated with a higher risk of subdural hematoma, according to a case-control study of more than 400,000...
News
Hemophilia repository open to US scientists
A new resource has been made available for US-based scientists studying hemophilia A and B. The resource—known as the My Life, Our Future...
News
CCSs’ subsequent cancer risk decreased from ’70s to ’90s
Childhood cancer survivors (CCSs) who were diagnosed in the 1990s have a lower risk of subsequent malignancies than CCSs diagnosed in the 1970s,...
News
FDA expands approved indication for lenalidomide
The US Food and Drug Administration (FDA) has approved a new indication for lenalidomide (Revlimid). The drug is now approved for use as...
News
VZV vaccine reduces HZ incidence after HSCT
ORLANDO, FL—Results of a phase 3 trial suggest an inactivated varicella zoster virus (VZV) vaccine known as V212 can reduce the risk of herpes...
News
Acquired mutations may compromise assay
A newly discovered issue with the Ba/F3 transformation assay could “jeopardize attempts to characterize the signaling mechanisms and drug...
News
Vaccine can fight different malaria strains
An investigational malaria vaccine can protect healthy adults from infection with a malaria strain different from that contained in the vaccine,...
News
FDA clears push-button blood draw device
The US Food and Drug Administration (FDA) has granted 510(k) clearance for a push-button blood collection device called TAP. It provides “...
News
CHMP recommends authorization of antiemetic agent
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the antiemetic...
News
CHMP advocates approval of edoxaban product
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that Roteas receive marketing authorization...
News
CHMP recommends new indication for daratumumab
The CHMP recommended approving daratumumab in combination with lenalidomide and dexamethasone or bortezomib and dexamethasone as treatment for...
News
Docs create guideline to aid workup of acute leukemia
Two physician groups have published an evidence-based guideline that addresses the initial workup of acute leukemia. The guideline includes 27...
News
First case of artemisinin resistance in Africa
Researchers have identified the first known case of artemisinin-resistant malaria originating in Africa, according to a letter published in NEJM...